Ji-Kwan Park, MD
Ophthalmology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Park’s office at (408) 436-3300 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A155176 · Current
Licensed to practise in California · since 2018 · expires 2027-09-30 · Loma Linda University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Medicaid work
$1,882 in 2023
Medicaid paid $1,882 for 36 billed services this clinician did in 2023, up to 16 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (30+ min) | 24 | $1,849 |
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 12 | $33 |
| 2023 | 36 | 2 | 16 | $1,882 |
| 2021 | 186 | 4 | 39 | $6,048 |
| 2020 | 103 | 3 | 31 | $2,924 |
See the largest Medicaid services in earlier years
2021
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 111 | $3,327 |
| OPH SVCS MEDICAL XM&EVAL COMPRE NEW PT 1/> VST | 47 | $2,116 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 16 | $311 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; optic nerve | 12 | $294 |
2020
| Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient | 73 | $1,721 |
| New patient visit (45+ min) | 12 | $909 |
| CLOSE TEAR DUCT OPENING | 18 | $294 |
Drugs they prescribed that Part D paid
$2,403
Pharmacies billed $2,403 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 9% of their Part D prescriptions (12 of 134) in 2024. A higher opioid share than 9 in 10 peers; the typical ophthalmology clinician is at 0%.
132 generic and fewer than 11 brand-name prescriptions · $2,403 in drug cost · 15 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Erythromycin | 50 | $717 | $14 |
| Neomycin-Polymyxin-Dexameth | 41 | $492 | $12 |
| Hydrocodone-Acetaminophen | 11 | $116 | $11 |
| Methylprednisolone | 11 | $106 | $10 |
Year by year
| 2024 | 134 | 81 | 9% (12) | None | $2,403 |
| 2023 | 75 | 65 | 20% (15) | None | $1,229 |
| 2022 | 85 | 67 | 39% (33) | 15% | $2,750 |
| 2021 | 1,072 | 346 | 2% (20) | 39% | $128,250 |
| 2020 | 571 | 267 | None | 42% | $40,867 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Neomycin-Polymyxin-Dexameth | 38 | $435 | $11 |
2022: 1 drug
| Hydrocodone-Acetaminophen | 29 | $160 | $6 |
2021: 16 drugs
| Restasis | 94 | $70,760 | $753 |
| Xiidra | 11 | $6,398 | $582 |
| Rhopressa | 13 | $5,908 | $454 |
| Travoprost | 18 | $5,177 | $288 |
| Prednisolone Acetate | 120 | $4,914 | $41 |
| Alphagan P | 15 | $3,466 | $231 |
| Olopatadine | 54 | $3,235 | $60 |
| Dorzolamide-Timolol | 68 | $3,000 | $44 |
| Latanoprost | 170 | $2,688 | $16 |
| Brimonidine | 81 | $1,553 | $19 |
| Erythromycin | 112 | $1,418 | $13 |
| Fluorometholone | 16 | $1,070 | $67 |
| Ofloxacin | 73 | $1,058 | $14 |
| Timolol Maleate | 49 | $675 | $14 |
| Neomycin-Polymyxin-Dexameth | 35 | $497 | $14 |
| Ketorolac Tromethamine | 14 | $250 | $18 |
2020: 14 drugs
| Restasis | 22 | $15,537 | $706 |
| Prednisolone Acetate | 132 | $5,244 | $40 |
| Pazeo | 18 | $3,868 | $215 |
| Travoprost | 13 | $2,374 | $183 |
| Erythromycin | 85 | $1,204 | $14 |
| Latanoprost | 51 | $1,108 | $22 |
| Ofloxacin | 69 | $1,025 | $15 |
| Fluorometholone | 11 | $852 | $77 |
| Brimonidine | 26 | $670 | $26 |
| Doxycycline Hyclate | 12 | $659 | $55 |
| Dorzolamide-Timolol | 14 | $588 | $42 |
| Olopatadine | 12 | $533 | $44 |
| Timolol Maleate | 19 | $321 | $17 |
| Neomycin-Polymyxin-Dexameth | 22 | $289 | $13 |
Money from drug and device companies
$31 in 2025
| 2025 | 1 | 1 | None | $31 |
| 2024 | 1 | 2 | None | $154 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| ANI Pharmaceuticals | Purified Cortrophin Gel | $31 | 1 payment
|
See the published payment
| ANI Pharmaceuticals | Meals · 2025-11-20 | Purified Cortrophin Gel | $31 |
See earlier years (2024)
2024: $154
| Abbvie | Botox | $154 | 2 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 77.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1619322898
- Licence
- CA A155176, IN 01084888ACalifornia A155176: Current · expires 2027-09-30
- Trained
- Loma Linda University School of Medicine, 2020
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207WX0200X (207WX0200X); Federal specialty code 207W00000X (207W00000X)
- Mailing address
- 1721 Technology Dr Dept 110, San Jose, CA, 95110
- NPI first listed
- 2016-04-26
- NPI last updated
- 2023-08-14
- NPI record certified
- 2023-08-14
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 333 City Blvd W, Orange, CA, 92868 · 555 N 13th Ave, Upland, CA, 91786
This office lists an electronic records connection.